home / stock / lly / lly news


LLY News and Press, Eli Lilly and Company From 06/12/24

Stock Information

Company Name: Eli Lilly and Company
Stock Symbol: LLY
Market: NYSE
Website: lilly.com

Menu

LLY LLY Quote LLY Short LLY News LLY Articles LLY Message Board
Get LLY Alerts

News, Short Squeeze, Breakout and More Instantly...

LLY - Powell And The Fed Are More Hawkish Than You Think: Expect Economic Weakness Ahead

2024-06-12 18:34:33 ET Summary At today's FOMC meeting, the Fed held interest rates steady and signaled that it's likely to cut less than the market thinks. This is somewhat surprising given that the econometric models I run are suggesting that the Fed has room to cut. Between...

LLY - Lilly's Retevmo gains traditional approval in thyroid cancer

2024-06-12 14:39:17 ET More on Eli Lilly Eli Lilly: The Road To Approval Of Donanemab Is Open Eli Lilly and Company (LLY) Goldman Sachs 45th Annual Global Healthcare Conference Is It Possible Eli Lilly Is Breaking Out To New All-Time Highs? GLP-1 obesity drug...

LLY - GLP-1 drug coverage dropped by Blue Cross Michigan: report

2024-06-12 12:33:43 ET More on Eli Lilly, Novo Nordisk, etc. Eli Lilly: The Road To Approval Of Donanemab Is Open Eli Lilly and Company (LLY) Goldman Sachs 45th Annual Global Healthcare Conference Is It Possible Eli Lilly Is Breaking Out To New All-Time Highs? ...

LLY - Palatin starts Phase 2 obesity study of bremelanotide with Zepbound

2024-06-12 10:27:30 ET More on Palatin Tech Palatin Technologies, Inc. (PTN) Q3 2024 Earnings Call Transcript Palatin Tech GAAP EPS of -$0.53 misses by $0.03 Palatin Tech Q3 2024 Earnings Preview Seeking Alpha’s Quant Rating on Palatin Tech His...

LLY - Madrigal Pharmaceuticals: The GLP-1 Threat May Be Overcooked

2024-06-12 10:16:29 ET Summary Madrigal Pharmaceuticals, Inc. stock has enjoyed peaks and troughs as it has pursued its path to the approval of NASH drug Rezdiffra. The company's stock was buoyant yesterday, enjoying a 15% gain after Wolfe Research initiated positive coverage. ...

LLY - Eli Lilly Continues To Climb As Alzheimer's Drug Gains FDA Approval

2024-06-11 14:24:55 ET Summary Eli Lilly and Company has gained approval on yet another prospective blockbuster drug, Donanemab, the second FDA-approved Alzheimer's treatment on the market. It is too soon to know what kind of impact Lilly’s Donanemab will have on future ear...

LLY - Eli Lilly: The Road To Approval Of Donanemab Is Open

2024-06-11 14:00:18 ET Summary Eli Lilly's stock has seen significant gains due to the success of its GLP-1 franchise and the potential of donanemab for Alzheimer's disease. The FDA's Advisory Committee endorsed donanemab for Alzheimer's treatment, but concerns remain post-approva...

LLY - Wall Street's most overbought stocks include NVDA, COST, LLY, and others

2024-06-11 13:25:29 ET The major market averages have shifted lower for the most part on Tuesday ahead of key inflation data and the Federal Reserve’s latest rate decision, but some stocks are still flashing signs of being overbought according to the relative strength index technical...

LLY - Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises

2024-06-11 08:45:53 ET Palm Beach, FL – June 11, 2024 – FN Media Group News Commentary – In the last twenty years, the amount of people with multiple sclerosis (MS) in the United States has more than doubled. In 2000, it was estimated by the National Multipl...

LLY - Eli Lilly Hits an All-Time High: Is the Soaring Pharma Stock Still a Buy?

2024-06-11 05:50:00 ET Johnson & Johnson reigned as the largest healthcare company in the world for years. UnitedHealth Group also took a turn at the top. However, the title now belongs to Eli Lilly (NYSE: LLY) -- and it isn't even close. Lilly continues to widen its...

Previous 10 Next 10